ALEXANDRIA, Va., Aug. 26 -- United States Patent no. 12,398,112, issued on Aug. 26, was assigned to Synthon B.V. (Nijmegen, Netherlands).
"Crystalline form of ozanimod hydrochloride" was invented by Raymond Westheim (Nijmegen, Netherlands).
According to the abstract* released by the U.S. Patent & Trademark Office: "The presented invention relates to crystalline form, Form A of Ozanimod hydrochloride, processes for preparation thereof and pharmaceutical compositions comprising the Ozanimod hydrochloride Form A."
The patent was filed on March 17, 2021, under Application No. 17/995,180.
*For further information, including images, charts and tables, please visit: http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnet...